News and Trends 14 Dec 2022
Etcembly reveals breakthrough in optimizing TCR assets
Etcembly has announced the successful prediction and optimization of multiple T cell receptor (TCR) assets for targeting leukemias and solid tumors. The company’s machine learning platform EMLy (Etcembly machine learning)…